InSphero AG

Name: InSphero AG
Address: Wagistrasse 27A, Schlieren, 8952, CH
Telephone: +41445150490
Price range: ££££

InSphero is a leading supplier of organotypic, biological microtissues for biomimetic drug testing. Dr. Dr. Simon P. Hoerstrup.

Headquarter in Switzerland with a US subsidiary, InSphero is a pioneer in 3D cell based technology engineered for highly predictive drug discovery and safety testing. The company, headquartered in Zurich, Switzerland, currently collaborates with more than ten global pharmaceutical and cosmetics companies to implement the company’s patent-pending microtissue technology in the customer’s development

work-flow. InSphero is a spin-off company of the Swiss Federal Institute of Technology (ETH) Zurich and the University Zurich and was founded in 2009 by Dr. Jan Lichtenberg, Dr. Jens Kelm, Dr. Wolfgang Moritz and Prof. InSphero has its production, laboratory and office space at the Technopark in Zurich, Switzerland. InSphero was recognized for its scientific and commercial achievements with a number of awards, including the VentureKick award, Heuberger Entrepreneurial Award and CTIstartup certification. InSphero’s founders combine more than 15 years of experience in microtissue engineering and over 10 years in microfluidics and laboratory automation with the goal to deliver highly functional, reliable and easy-to-use microtissues. InSphero AG
Technoparkstrasse 1
CH-8005 Zurich
Switzerland

Tel.: +41-44-515049-0
Fax +41-44-515049-1

04/03/2021

In case this isn't already on your radar, today at 10 AM,
New Frontiers in 3D is hosting a KOL roundtable on industrial applications for systems. It should be a fascinating discussion! Hope you can join us.

https://newfrontiersin3d.com/program/

This event is sponsored by InSphero AG

Fostering discussion of transformative 3D in vitro cell technologies from advanced disease modeling to organ-on-a-chip solutions with virtual KOL roundtables, in-person and digital symposia, and curated 3D in vitro news digests.

23/02/2021

Join New Frontiers in 3D for a virtual fireside chat about industrial applications for complex, yet scalable in vitro models for drug discovery. In this live, interactive roundtable, Jaap den Toonder, Peter Loskill, Florian Fuchs, and Olivier Frey will discuss the importance of balancing experimental complexity and scalability, and how thoughtful engineering can ensure successful translation from academia to industry.

https://newfrontiersin3d.com/program/

,

14/02/2021

If you missed the first New Frontiers in 3D first KOL roundtable on animal-free safety testing, it is now available as an podcast. Listen to panelists Dr. Stefan Platz from AstraZeneca, Prof. Thomas Hartung of Johns Hopkins University Bloomberg School of Public Health, and Prof. Armin Wolf from InSphero AG, discuss challenges and opportunities for animal-free drug safety testing -- and the move toward applying in vitro and in silico models in drug development to improve translation to patients.
https://newfrontiersin3d.com/program/ -free

19/01/2021

Join us for a fireside chat with visionaries who are leading the way toward implementing animal-free methods that better predict the patient response to new drugs. In this interactive virtual roundtable, Thomas Hartung, Stefan Platz, and Armin Wolf Prof, PhD will discuss important scientific questions that all researchers involved in drug R&D should consider as regulatory agencies, such as the US Environmental Protection Agency (EPA), move to stop supporting and funding research using animal models by 2035 or sooner.

• Do animals predict human drug safety correctly?
• How can we increase predictivity of drug safety?
• What are the challenges for evaluating new modalities?
• What are the most promising new technologies?
• What will drug safety risk assessment look like in 2030?

Tuesday, January 26
7 AM PST |10 AM EST | 4PM CET
https://newfrontiersin3d.com/program/ -free

07/12/2020

Subscribe and stay informed. Latest news in 3D in vitro technologies from research, emerging technologies, valuable applications to commercial successes in the field.

Call for abstracts for the 2019 New Frontiers in 3D Cell Technologies conference. Share your work with innovators and researcher applying organ-on-a-chip technologies, advanced disease modeling, alternatives to animal testing, and drug safety testing.

08/11/2020

InSphero team members pose with then-Vice President Joe Biden at AACR 2016. 🙂 Although we usually avoid talking politics on social media, we are looking forward to a new US administration that invests and believes in science!

28/08/2020

InSphero and the Bio Engineering Lab at ETH Zürich achieved a significant new milestone to commercialize our Akura™ Flow technology platform for solutions. This agreement marks the culmination of close to a decade of innovative bioengineering and integrative biomedical research efforts. Kudos to Olivier Frey and Andreas Hierlemann's team at ETH Zurich Basel for their ground-breaking work in the field of for drug discovery. And many thanks to the and Innosuisse - Swiss Innovation Agency for funding support.

https://insphero.com/media-release/akura-flow-technology-milestone/

05/08/2020

If you're working with our assay-ready models, you may be interested in a new two-part webinar series, organized by InSphero and Promega, one of our key technology partners. It kicks off on August 12 with a presentation on 3D assays and models for diabetes research led by Terry Riss, a Senior Product Manager at Promega, who also taught an SLAS short course on 3D cell-based assays for drug de-risking with us earlier this year. InSphero Research Scientist Joan Mir Coll will discuss the Promega bioluminescent assays our islet team relies on and present results from recent studies using 3D InSight™ Human Islet Microtissues.
https://insphero.com/science/digital-media/webinars/ -1

04/08/2020

We're pleased to announce that the InSphero InFloat™ Live Microtissue Shipping System won the Red Dot Best-of-the-Best Award for Product Design! Congratulations to David Fluri, Jan Lichtenberg, and Olivier Frey -- the design team behind this revolutionary new shipping technology! Here they are posing with an early prototype of the spherical container engineered to securely transport boxes of assay-ready 3D InSight™ microtissues.
https://insphero.com/media-release/insphero-wins-red-dot-award/

Adresse

Wagistrasse 27A
Schlieren
8952

Telefon

+41445150490

Webseite

http://www.insphero.com/

Benachrichtigungen

Lassen Sie sich von uns eine E-Mail senden und seien Sie der erste der Neuigkeiten und Aktionen von InSphero AG erfährt. Ihre E-Mail-Adresse wird nicht für andere Zwecke verwendet und Sie können sich jederzeit abmelden.